This episode of Pharma Pulse covers the Trump administration’s 100% tariff on branded drug imports, new research linking pediatric influenza to neurological complications amid vaccination gaps, and ...
Omnichannel orchestration: Enables tailored messages across platforms in real time to meet the patient or HCP where they are with what they need. Whether it’s through email, social media, HCP portals, ...
This episode of Pharma Pulse covers new research showing Medicaid cuts could widen pediatric coverage gaps, clinical trial ...
Through its “BMS Patient Connect” platform, the company is lowering out-of-pocket costs and providing nationwide shipping, ...
Beginning Oct. 1, the US will impose a 100% tariff on branded and patented pharmaceutical imports unless manufacturers are ...
This episode of Pharma Pulse covers the CDC’s unanimous vote to broaden COVID-19 vaccine recommendations for all adults, new ...
Closed Loop Medicine Debuts WeDosify in US to Personalize GLP-1 Dosing and Improve Patient Adherence
The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...
This episode of Pharma Pulse covers ACIP’s move toward shared decision-making for COVID-19 vaccines, Pfizer’s acquisition of ...
This episode of Pharma Pulse covers the CDC’s decision to postpone changes to Hepatitis B vaccine guidance, new research ...
Ullrich Mayeski, community engagement director of health with GS1 US, explains how with over a decade of collaboration, ...
Capturing insights from executives and industry experts on the biggest challenges shaping pharma today, from drug pricing pressures and access barriers to supply chain shifts, digital adoption, and ...
The South Korean pharma company’s US subsidiary is purchasing Eli Lilly’s Branchburg, NJ site to safeguard against potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback